Regulation of the alpha 1(I) collagen promoter in vascular smooth muscle cells. Comparison with other alpha 1(I) collagen-producing cells in transgenic animals and cultured cells. 1994

A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
Department of Pediatrics, University of Connecticut Health Center, Farmington 06032.

We have previously reported that the expression of the ColCAT3.6 transgene containing 3.5 kilobases (kb) of alpha 1(I) collagen (COL1A1) promoter sequence fused to the chloramphenicol acetyltransferase (CAT) reporter gene paralleled the expression of the endogenous gene in several connective tissues. We report here that the activity of the reporter gene in aorta from 7-day-old transgenic mice is 10-64-fold lower than in tendon or bone, whereas the endogenous gene is highly expressed in all three tissues. In contrast, the COL1A1 minigene containing 2.3 kb of upstream sequence, the first five exon/intron units, the last six exon/intron units, and 2 kb of 3'-flanking sequence showed high CAT activity in aorta. These results suggest that cis sequences found in ColCAT3.6 mediate high levels of COL1A1 expression in bone and tendon, but not in vascular smooth muscle cells (VSMC), whereas sequences located within the minigene, but not found in ColCAT3.6, mediate VSMC-specific expression. Analysis of promoter activity in cultured cells derived from transgenic tissues further suggests the presence of VSMC-specific regulatory domains. Transient transfection studies, however, failed to shows differential regulation. These differences stress the importance of not relying exclusively on transient transfection data when mapping tissue-specific regulatory domains.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
September 1995, Biochemistry and molecular biology international,
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
January 2009, Journal of vascular research,
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
January 1984, Hypertension (Dallas, Tex. : 1979),
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
January 2001, Journal of cardiovascular pharmacology,
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
February 1990, Journal of cellular physiology,
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
March 1993, Molecular endocrinology (Baltimore, Md.),
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
January 2000, Life sciences,
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
February 2012, Amino acids,
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
January 2003, The Journal of surgical research,
A Bedalov, and D T Breault, and B P Sokolov, and A C Lichtler, and I Bedalov, and S H Clark, and K Mack, and J S Khillan, and C O Woody, and B E Kream
April 1996, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!